Mitchell E. Levinson - Nov 15, 2023 Form 4 Insider Report for Pulse Biosciences, Inc. (PLSE)

Role
Chief Strategy Officer
Signature
/s/ Kenneth B. Stratton, as Attorney-in-Fact
Stock symbol
PLSE
Transactions as of
Nov 15, 2023
Transactions value $
$105,090
Form type
4
Date filed
11/17/2023, 09:10 AM
Previous filing
Nov 3, 2023
Next filing
Jul 8, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PLSE Common Stock Purchase $2.69K +461 +0.67% $5.83 69.2K Nov 15, 2023 Direct
transaction PLSE Common Stock Purchase $22.3K +3.8K +5.49% $5.88 73K Nov 15, 2023 Direct
transaction PLSE Common Stock Purchase $29.7K +5K +120.92% $5.94 9.14K Nov 15, 2023 Spouse
transaction PLSE Common Stock Purchase $1.18K +200 +27.25% $5.92 934 Nov 15, 2023 Immediate Family Member (1)
transaction PLSE Common Stock Purchase $13.7K +2.3K +246.25% $5.94 3.23K Nov 15, 2023 Immediate Family Member (1)
transaction PLSE Common Stock Purchase $594 +100 +13.62% $5.94 834 Nov 15, 2023 Immediate Family Member (2)
transaction PLSE Common Stock Purchase $14K +2.4K +287.77% $5.85 3.23K Nov 15, 2023 Immediate Family Member (2)
transaction PLSE Common Stock Purchase $590 +100 +13.62% $5.90 834 Nov 15, 2023 Immediate Family Member (3)
transaction PLSE Common Stock Purchase $13.9K +2.4K +287.77% $5.80 3.23K Nov 15, 2023 Immediate Family Member (3)
transaction PLSE Common Stock Purchase $6.37K +1.04K $6.13 1.04K Nov 15, 2023 Immediate family member (4)
* An asterisk sign (*) next to the price indicates that the price is likely invalid.